特一药业：前三季度净利润同比增长985.18%

Core Insights - The company reported significant growth in both revenue and net profit for the third quarter of 2025, with a revenue of 201 million yuan, representing a year-on-year increase of 41.49% [1] - The net profit attributable to shareholders reached 27.21 million yuan, showing a remarkable year-on-year growth of 719.47% [1] - For the first three quarters of 2025, the company achieved a total revenue of 692 million yuan, which is a 51.86% increase compared to the same period last year [1] - The net profit for the first three quarters was 65.22 million yuan, reflecting an impressive year-on-year growth of 985.18% [1] - The sales revenue from traditional Chinese medicine products saw a significant increase during the reporting period [1]